TECH (STOCKS)
Bio-Techne Corp.
$57.530000
+1.990000 (+3.58%)
Prev close: $55.540000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Kim Kelderman
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $9,002.32M
- Employees
- 3,100
- P/E (TTM)
- 108.03
- P/B (TTM)
- 4.31
- Dividend Yield
- 57.62%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
10
Buy
6
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q2)
|
$0.46 | $0.44 | +0.0175 | +3.95% |
|
Sep 2025 (Q1)
|
$0.42 | $0.43 | -0.0087 | -2.03% |
|
Jun 2025 (Q4)
|
$0.53 | $0.51 | +0.0211 | +4.15% |
|
Mar 2025 (Q3)
|
$0.56 | $0.52 | +0.0384 | +7.36% |
Financial Statements
| Revenues | $1.22B |
| Benefits Costs and Expenses | $1.10B |
| Cost Of Revenue | $422.82M |
| Costs And Expenses | $1.10B |
| Gross Profit | $792.76M |
| Nonoperating Income/Loss | -$2.78M |
| Operating Expenses | $675.79M |
| Selling, General, and Administrative Expenses | $577.81M |
| Other Operating Expenses | $97.98M |
| Operating Income/Loss | $116.97M |
| Income/Loss Before Equity Method Investments | $113.27M |
| Income/Loss From Continuing Operations After Tax | $81.10M |
| Income/Loss From Continuing Operations Before Tax | $114.19M |
| Income/Loss From Equity Method Investments | $922.00K |
| Income Tax Expense/Benefit | $33.09M |
| Net Income/Loss | $81.10M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $81.10M |
| Net Income/Loss Available To Common Stockholders, Basic | $81.07M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $64.00K |
| Preferred Stock Dividends And Other Adjustments | $32.00K |
| Undistributed Earnings/Loss Allocated To Participating Securities, Basic | $45.00K |
| Basic Earnings Per Share | $0.52 |
| Diluted Earnings Per Share | $0.51 |
| Basic Average Shares | 468,079,000 |
| Diluted Average Shares | 471,360,000 |
| Assets | $2.52B |
| Current Assets | $637.43M |
| Inventory | $205.45M |
| Other Current Assets | $431.99M |
| Noncurrent Assets | $1.89B |
| Fixed Assets | $234.38M |
| Intangible Assets | $334.99M |
| Other Non-current Assets | $1.32B |
| Liabilities | $511.71M |
| Current Liabilities | $140.43M |
| Accounts Payable | $26.27M |
| Wages | $45.03M |
| Other Current Liabilities | $69.13M |
| Noncurrent Liabilities | $371.28M |
| Equity | $2.01B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $2.01B |
| Liabilities And Equity | $2.52B |
| Net Cash Flow From Operating Activities | $249.32M |
| Net Cash Flow From Operating Activities, Continuing | $249.32M |
| Net Cash Flow From Investing Activities | -$13.78M |
| Net Cash Flow From Investing Activities, Continuing | -$13.78M |
| Net Cash Flow From Financing Activities | -$251.69M |
| Net Cash Flow From Financing Activities, Continuing | -$251.69M |
| Net Cash Flow | -$16.15M |
| Net Cash Flow, Continuing | -$16.15M |
| Comprehensive Income/Loss | $104.41M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $104.41M |
| Other Comprehensive Income/Loss | $23.31M |